home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

RNA From Blood To Brain

 
  June, 27 2007 8:45
your information resource in human molecular genetics
 
     
It is now possible to perform gene therapy on the brain via intravenous injection, in mice at least. The finding, reported in Nature, opens a new potential line of noninvasive treatment for neuronal disease.

Getting any drug into the brain can be a problem because the blood-brain barrier acts as a barricade keeping systemic treatments out. Manjunath N. Swamy and colleagues show that when small fragments of RNA attached to a piece of viral protein are injected into the bloodstream of mice infected with a fatal form of encephalitis, the RNA-protein complex travels to the brain. The protein part binds neuronal cells, delivering the RNA part, which becomes internalised and can silence key genes through a process called RNA interference. The result - about 80% of treated animals survived, whilst all of the non-treated animals died.

Although the method needs tweaking to improve efficiency, the technique may offer a useful way of delivering nucleic acids and small-molecule drugs into the brain.

Author contact:

Manjunath N. Swamy (CBR Institute for Biomedical Research, Boston, MA, USA)
E-mail: swamy@cbrinstitute.org

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.